INS and cystic fibrosis-related diabetes: Although not currently used to diagnose CFRD, CGM-detected dysglycemia among individuals with CF and normal glucose tolerance correlates with early abnormalities in insulin secretion and declines in pulmonary function.91 Future studies investigating the impact of CGM on glycemic control, pulmonary function, weight, or quality of life in patients with CFRD are needed.92